Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharma Intelligence Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Center Today - Breaking & Trending Today

ASH 2021: site selection key in reducing enrolment disparity in cancer trials - Vimarsana News

ASH 2021: site selection key in reducing enrolment disparity in cancer trials

Diversity, equity, and inclusion in clinical trials was a hot topic at the recent Annual Meeting of the American Society of Hematology (ASH).

Diffuse Large B-cell Lymphoma (DLBCL) Pipeline Guide 2021 - Vimarsana News

Diffuse Large B-cell Lymphoma (DLBCL) Pipeline Guide 2021

/PRNewswire/ -- The "Diffuse Large B-cell Lymphoma (DLBCL) - Competitive Landscape in 2021" report has been added to ResearchAndMarkets.com's offering. The...

Indian home-grown Covid-19 shot wins WHO emergency use approval - Vimarsana News

Indian home-grown Covid-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown Covid-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.

Source: news24.com
Indian home-grown COVID-19 shot wins WHO emergency use approval - Vimarsana News

Indian home-grown COVID-19 shot wins WHO emergency use approval

The World Health Organization on Wednesday said it had approved Indian drugmaker Bharat Biotech's COVID-19 vaccine for emergency use, paving the way for the homegrown shot to be accepted as a valid...

Indian home-grown COVID-19 shot wins WHO emergency use approval - Vimarsana News

Indian home-grown COVID-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown COVID-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.